Patient and Surgeon Candidacy for Transoral Endoscopic Thyroid Surgery.
Fausto Fama'Daqi ZhangAlessandro PontinÖzer MakayRalph P TufanoHoon Yub KimHui SunGianlorenzo DionigiPublished in: Turkish archives of otorhinolaryngology (2019)
The transoral thyroidectomy (TT) is a feasible novel surgical procedure that does not need visible incisions, a truly cutaneous scar-free surgery. Inclusion criteria are (a) patients who have a ultrasonographically (US) estimated thyroid diameter not larger than 10 cm, (b) US estimated gland volume ≤45 mL, (c) nodule size ≤50 mm, (d) a benign tumor, such as a thyroid cyst, single-nodular goiter, or multinodular goiter, (e) follicular neoplasm, and (f) papillary microcarcinoma without evidence of metastasis. The procedure is carried out through a three-port technique placed at the oral vestibule; one 10-mm port for a 30° endoscope and two additional 5-mm ports for dissecting and coagulating instruments. CO2 insufflation pressure is set at 6 mmHg. An anterior cervical subplatysmal space is created from the oral vestibule down to the sternal notch, laterally to the sternocleidomastoid muscle medial edges. TT is done fully endoscopically using conventional endoscopic instruments.
Keyphrases
- minimally invasive
- robot assisted
- end stage renal disease
- papillary thyroid
- coronary artery bypass
- patient reported outcomes
- ultrasound guided
- lymph node metastasis
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- endoscopic submucosal dissection
- cell proliferation
- surgical site infection
- skeletal muscle
- low grade
- squamous cell carcinoma
- laparoscopic surgery
- acute coronary syndrome
- high grade
- optic nerve
- wound healing
- percutaneous coronary intervention